Withus Pharmaceutical, 19.5 Billion KRW Facility Investment
[Asia Economy Reporter Minwoo Lee] Withus Pharmaceutical announced on the 23rd that it has decided to invest 19.5 billion KRW in new facility investment and factory construction to produce long-acting injectable drugs for hair loss treatment and to diversify its injectable drug business. This amount corresponds to 25.37% of the company's equity capital based on consolidated financials from last year.
Hot Picks Today
"Only Two Per Person" Garbage Bag Crisis Was Just Yesterday... Japan Also Faces Shortage Anxiety
- "Samsung Electronics Employee with 100 Million Won Salary Receiving 600 Million Won Bonus... Estimated Tax Revealed"
- Lived as Family for Over 30 Years... Daughter-in-Law Cast Aside After Husband's Death
- 'Will Demand Finally Decline Due to High Prices?'... "I'll Just Enjoy Nearby Trips" as Japan and China See a Surge
- "Wore It Once, Then This? White Spots All Over 4.15 Million Won Prada Jacket... 'Full Refund Ordered'"
Withus Pharmaceutical explained, "We will build a dedicated microfluidic factory and an automated logistics warehouse with a total area of 2,228 pyeong, consisting of one basement floor and seven above-ground floors, on the existing Anseong factory site."
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
